Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
ICSH recommendations for the measurement of haemoglobin A2.
|
Int J Lab Hematol
|
2011
|
2.23
|
2
|
The molecular basis of Hb H disease in Turkey.
|
Hemoglobin
|
1997
|
1.24
|
3
|
Sickle cell membranes and oxidative damage.
|
Biochem J
|
1986
|
1.20
|
4
|
alpha-thalassemia in the United Arab Emirates.
|
Acta Haematol
|
1998
|
1.15
|
5
|
Inhibition of hemin-induced hemolysis by desferrioxamine: binding of hemin to red cell membranes and the effects of alteration of membrane sulfhydryl groups.
|
Biochim Biophys Acta
|
1992
|
1.06
|
6
|
Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients.
|
Am J Hematol
|
1993
|
1.02
|
7
|
Hb H disease in a Turkish family resulting from the interaction of a deletional alpha-thalassaemia-1 and a newly discovered poly A mutation.
|
Br J Haematol
|
1992
|
0.99
|
8
|
Molecular characterization of Hb S(C) beta-thalassemia in American blacks.
|
Am J Hematol
|
1991
|
0.98
|
9
|
A mild type of Hb S-beta(+)-thalassemia [-92(C-->T)] in a Sicilian family.
|
Am J Hematol
|
1993
|
0.92
|
10
|
Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs.
|
Acta Haematol
|
1994
|
0.92
|
11
|
Types of thalassemia among patients attending a large university clinic in Kuala Lumpur, Malaysia.
|
Hemoglobin
|
1992
|
0.90
|
12
|
Polymorphic pattern of the (AT)X(T)Y motif at -530 5' to the beta-globin gene in over 40 patients homozygous for various beta-thalassemia mutations.
|
Am J Hematol
|
1994
|
0.89
|
13
|
The relative levels of alpha 2-, alpha 1-, and zeta-mRNA in HB H patients with different deletional and nondeletional alpha-thalassemia determinants.
|
Biochim Biophys Acta
|
1996
|
0.88
|
14
|
A novel beta zero-thalassaemia mutation (codon 15, TGG----TGA) is prevalent in a population of central Portugal.
|
Br J Haematol
|
1992
|
0.87
|
15
|
A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3'HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin?
|
Blood
|
1994
|
0.86
|
16
|
t-butyl hydroperoxide-induced perturbations of human erythrocytes as a model for oxidant stress.
|
Biochim Biophys Acta
|
1985
|
0.85
|
17
|
Radio-protective effects of Nigella sativa oil on oxidative stress in tongue tissue of rats.
|
Oral Dis
|
2013
|
0.84
|
18
|
Iron-mediated oxidative stress in erythrocytes.
|
Biochem J
|
1987
|
0.84
|
19
|
Oxidative effects of iron on erythrocytes.
|
Free Radic Res Commun
|
1985
|
0.83
|
20
|
Molecular characterization of beta-thalassemia in Azerbaijan.
|
Hum Genet
|
1992
|
0.81
|
21
|
A large beta-thalassemia deletion in a family of Indonesian-Malay descent.
|
Hemoglobin
|
1996
|
0.81
|
22
|
Assessment of the ear and otoacoustic emission findings in fibromyalgia syndrome.
|
Clin Exp Rheumatol
|
2005
|
0.81
|
23
|
Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations.
|
Hum Genet
|
1994
|
0.80
|
24
|
A de novo deletion causing epsilon gamma delta beta-thalassemia in a Dutch patient.
|
Acta Haematol
|
1996
|
0.80
|
25
|
Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates.
|
Pediatr Hematol Oncol
|
1998
|
0.80
|
26
|
Beta-thalassemia mutations in the Portuguese; high frequencies of two alleles in restricted populations.
|
Hemoglobin
|
1993
|
0.79
|
27
|
Management of incus long process defects: incus interposition versus incudostapedial rebridging with bone cement.
|
J Laryngol Otol
|
2013
|
0.79
|
28
|
Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with beta-thalassaemia due to a homozygosity for the IVS-I-6 (T-->C) mutation.
|
Br J Haematol
|
1994
|
0.79
|
29
|
Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family.
|
Ann Hematol
|
1991
|
0.78
|
30
|
Hb H disease caused by a homozygosity for the AATAAA-->AATAAG mutation in the polyadenylation site of the alpha 2-globin gene: hematological observations.
|
Acta Haematol
|
1992
|
0.78
|
31
|
Hb Costa Rica or alpha 2 beta 2 77(EF1)His --> Arg: the first example of a somatic cell mutation in a globin gene.
|
Hum Genet
|
1996
|
0.78
|
32
|
The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes.
|
FEBS Lett
|
1989
|
0.77
|
33
|
Hb Coimbra or alpha 2 beta (2)99(G1)Asp----Glu, a newly discovered highoxygen affinity variant.
|
Hemoglobin
|
1991
|
0.77
|
34
|
A Canadian family with Hb Wayne; characterization by HPLC and DNA sequencing.
|
Hemoglobin
|
1992
|
0.77
|
35
|
Rare beta-thalassemia mutation IVS-II-848 (C-A) first reported in a Turkish Cypriot family.
|
Am J Hematol
|
1997
|
0.77
|
36
|
Role of methylprednisolone in the prevention of postpericardiotomy syndrome after cardiac surgery.
|
Eur Rev Med Pharmacol Sci
|
2016
|
0.77
|
37
|
ICSH recommendations for the measurement of haemoglobin F.
|
Int J Lab Hematol
|
2011
|
0.76
|
38
|
Beta-thalassemia alleles and unstable hemoglobin types among Russian pediatric patients.
|
Am J Hematol
|
1994
|
0.76
|
39
|
Alpha-Thalassemia and fetal hemoglobin.
|
Blood
|
1994
|
0.76
|
40
|
The unstable Hb Hammersmith or alpha 2 beta 2(42)(CD1)Phe----Ser observed in an Indian child; identification by HPLC and by sequence analysis of amplified DNA.
|
Hemoglobin
|
1992
|
0.75
|
41
|
The role of high frequency tympanometry in newborn hearing screening programme.
|
Eur Rev Med Pharmacol Sci
|
2012
|
0.75
|
42
|
An IVS-I-117 (G-->A) acceptor splice site mutation in the alpha 1-globin gene is a nondeletional alpha-thalassaemia-2 determinant in an Indian population.
|
Br J Haematol
|
1993
|
0.75
|
43
|
The T-->C mutation at position +96 of the untranslated region 3' to the terminating codon of the beta-globin gene is a rare polymorphism that does not cause a beta-thalassemia as previously ascribed.
|
Hum Genet
|
1994
|
0.75
|
44
|
A Czechoslovakian teenager with Hb E-beta zero-thalassemia [IVS-I-1 (G----A)] complicated by the presence of an alpha-globin gene triplication.
|
Ann Hematol
|
1991
|
0.75
|
45
|
Black beta-thalassemia homozygotes with specific sequence variations in the 5' hypersensitive site-2 of the locus control region have high levels of fetal hemoglobin.
|
Am J Hematol
|
1992
|
0.75
|
46
|
Factors associated with hypochromia and microcytosis among high school students in the southeastern United States.
|
South Med J
|
1994
|
0.75
|
47
|
Hb Bibba or alpha 2 136(H19)Leu-->Pro beta 2 in a Caucasian family from Alabama.
|
Hemoglobin
|
1995
|
0.75
|
48
|
Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes.
|
Acta Haematol
|
1987
|
0.75
|
49
|
Thalassemia intermedia in two patients with Hb Lepore-beta zero-thalassemia (Frameshift codon 8, -AA).
|
Hemoglobin
|
1994
|
0.75
|
50
|
Needle in the heart.
|
Herz
|
2013
|
0.75
|
51
|
Value of the neutrophil-to-lymphocyte ratio in predicting post-pericardiotomy syndrome after cardiac surgery.
|
Eur Rev Med Pharmacol Sci
|
2016
|
0.75
|
52
|
Quantities of alpha Q chain variants in heterozygotes with and without a concomitant beta-thalassemia trait.
|
Am J Hematol
|
1994
|
0.75
|
53
|
Hb Mizuho or alpha 2 beta (2)68(E12)Leu----Pro in a Caucasian boy with high levels of Hb F; identification by sequencing of amplified DNA.
|
Hemoglobin
|
1991
|
0.75
|